Clinical Trial Update: White Blood Cell Infusions to Treat HIV Infection [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial investigated white blood cell infusions as a treatment for HIV infection/AIDS, sponsored by NIAID. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• White blood cell infusion therapy

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Acquired Immunodeficiency Syndrome, HIV Infection | Phase 1 | Status: COMPLETED